Scanfil and Liquid Instruments have signed a manufacturing outsourcing agreement for Scanfil’s Melbourne plant in Australia. This agreement supports Liquid Instruments’ strategy to onshore production of its flagship Moku platform, strengthening domestic supply chains and bringing manufacturing closer to its research and development hub.
“We’re continuing to expand our manufacturing footprint in Australia,” says Daniel Shaddock, CEO of Liquid Instruments. “Onshoring production through this partnership allows us to scale more efficiently, while deepening our investment in Australia’s technology ecosystem. Scanfil’s expertise and strong local presence make them the ideal partner for this next phase of growth.”
The collaboration will leverage Scanfil’s and its subsidiary, SRXGlobal’s, expertise in Medtech & Life Science. Liquid Instruments will benefit from supply chain management, scalable manufacturing, global delivery capabilities, and aftermarket services — all in Victoria, Australia.
“Liquid Instruments has developed a unique product with an interesting and complex technology that is a perfect fit for the services provided by SRXGlobal in Australia. We at Scanfil and SRXGlobal are thrilled and excited that Liquid Instruments has chosen SRXGlobal as their preferred manufacturing partner for the exciting journey ahead, and we look forward to a strong and successful partnership”, states Christian Kesten, VP of Scanfil APAC.
More related news:
Proteintech Launches Next-Gen 3D Epitope Mapping to Boost Life Science Research
ACROMETA signs sales & purchase agreement for additional 40% of Life Science Incubator
Maryland Tech Council and BIOQuébec collaborate to promote life sciences
